Alan Y – Cohort studies

Alan Y’s participation in a medical cohort study came about when he spent time in hospital with a suspected transient ischemic attack (TIA). His two main motivations to take part were to understand why someone like him with an active and healthy lifestyle was affected with a health condition and, secondly, because he wants to help other people.

Alan Y’s participation in a medical cohort study came about when he spent time in hospital with a suspected transient ischemic attack (TIA). His main motivations to take part in the medical cohort were to understand why he was ill and to help others: “I thought, if I can help other people and find out why I had the TIA – because I was fit, I don’t really drink a lot. I don’t smoke. I’m very active – and why was I, all of a sudden, on this bed hooked up to all the wires?”

Alan Y’s father had high blood pressure and high cholesterol, but Alan Y and his siblings were unaware of it. Alan Y, in turn, made his daughters aware about these medical conditions running in the family and both have recorded them in their medical records. Alan Y says, “awareness is the biggest thing.”

Over the last 10 years, and as part of his participation in the medical cohort, Alan Y has had regular reviews. Initially, “there was lots of tests at the time and there was a 1 month follow-up, I think, and then regular, it was probably 1 month, 3 months, 6 months, during the first year, with repetition of the same tests.” Tests have included blood tests, electrocardiograms, monitoring of new medications, memory, writing, and copying pictures tests “to test my brain function to make sure it was still there.”

He feels reassured that the medical cohort has his medical records and the team gave Alan Y a telephone number in case he needs to contact them. Last year, he needed their medical advice following eye surgery to remove a cataract. His vision did not recover as expected and doctors suspected a TIA in the back of the eye. The medical cohort team saw him, conducted tests, and were able to eliminate the TIA as a possible cause.

Alan Y feels well supported by the medical cohort team because there is someone there at the end of the phone and the GP knows that as well and can refer me straight there if she thinks I need to g. Moreover, he is also aware of the risk of people becoming over-reliant on the yearly check-ups provided by the medical cohort and developing a passive attitude, “like, ‘I’m taking the tablets, they’re seeing me next year. I don’t have to do anything else’.”.

He says that the information received from the cohort study has been fine, but he found that the most important thing was the opportunity to meet a health professional and to be able to ask questions, receive answers and “being able to actually talk to someone, rather than read it.”

Before experiencing a suspected TIA and his participation in the medical cohort, Alan Y had a healthy lifestyle, but said that through participation in the cohort, he has become more aware of the life, exercise and recreation balance: “So, it’s being able to say, No; and just slow down and enjoy the grandchildren.”

Interview conducted in 2019.

Alan Y has had regular contact with the study team over the ten year study.

Age at interview 68

Gender Male

When Alan Y had new symptoms that he wondered might be related to a transient ischaemic attack (TIA), it was reassuring to know he could talk to the research team who had access to his medical files and could advise him.

Age at interview 68

Gender Male

Alan Y contacted the research team because he has a history of transient ischaemic attack (TIA) and was worried about his eye. The extra tests were reassuring for him, and he thinks the results will be useful to the study too.

Age at interview 68

Gender Male

Alan Y was approached about taking part in a cohort study whilst recovering from a transient ischaemic attack (TIA) in hospital.

Age at interview 68

Gender Male

Alan Y doesn’t remember a lot about the information he initially received but recalls that it was helpful to discuss with a member of the research team in person soon afterwards.

Age at interview 68

Gender Male